Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...

UCB’s Bimzelx is firmly on physicians’ radars, with Spherix Global Insights finding that awareness of the drug was tracking ...

Psoriatic Arthritis, Crohn's Disease, and Ulcerative Colitis for Skyrizi, and Rheumatoid Arthritis, Psoriatic Arthritis, Atopic Dermatitis, Ulcerative Colitis, Crohn's Disease, Ankylosing ...

Skyrizi and Rinvoq are expected to generate nearly $24 billion in combined sales in 2025, reflecting a $6 billion increase year-over-year. AbbVie raised its 2027 combined sales guidance for these ...

The decline was offset by sales of its newer arthritis drugs Skyrizi, which soared by 57% to $3.78 billion, and Rinvoq, which logged a 46% gain to $1.83 billion. Chief Executive Robert Michael ...

Rheumatoid arthritis and osteoarthritis are two of the most common types of arthritis, but they differ in causes, symptoms, and treatment. Understanding the differences is important for proper ...

“Psoriatic arthritis is a complex disease ... Some analysts meanwhile have suggested Tremfya’s biggest challenge will be to stay ahead of Skyrizi, which has been proposed as a ‘best-in ...

Psoriatic arthritis (PsA) a type of arthritis affecting joints. PsA may also involve enthesitis, a condition that affects ligaments and tendons where they connect to bone. Psoriatic arthritis (PsA ...

Today, a brief rundown of news involving Novartis and AbbVie, as well as updates from Biogen, Merck & Co. and Sanofi that you may have missed. Expected readouts in diabetes, cancer and depression ...

The Reds have already secured a top-eight finish in the league phase after seven straight wins, ensuring they are through to the knockout stage whatever happens in the Netherlands after Slot’s ...